Selenium Wastewater Treatment Using Iron Coagulation and Sulfite Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Industrial wastewaters containing toxic metals and oxyanions, particularly selenium, pose challenges due to stringent regulatory limits, necessitating low-cost and efficient treatment methods.
Innovation Solution
A method involving the use of iron-containing coagulants, such as ferrous chloride, and sodium sulfite-based reducing agents, like sodium metabisulfite, is applied to treat industrial fluids, adjusting pH to 9-10, followed by flocculation and separation to remove selenium effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatment methods are used, then cost is reduced, but selenium removal efficiency is insufficient to meet stringent regulatory limits
Solution Approach 1:
The patent changes chemical parameters by using iron-containing coagulants (Fe2+ or Fe3+) combined with sulfite-based reducing agents (SO3 2- or HSO3 -) to transform selenium species into removable forms. This chemical parameter transformation enables high removal efficiency while maintaining cost-effectiveness through readily available reagents
Solution Approach 2:
The patent employs a composite treatment approach combining multiple chemical agents (coagulant + reducing agent) that work synergistically. The iron coagulant provides coagulation function while the sulfite reducing agent transforms selenium oxidation states, creating a composite chemical system that achieves superior removal efficiency compared to single-agent treatments
2Reliability
If treatment time is extended to improve selenium removal, then removal efficiency increases, but processing productivity decreases
Solution Approach 1:
The patent applies preliminary chemical conditioning by adding iron coagulants and sulfite reducing agents before the main treatment process. This preliminary action pre-transforms selenium into forms that settle and separate more rapidly, reducing the overall treatment time required while maintaining high removal efficiency
Solution Approach 2:
The patent utilizes phase transition of selenium from dissolved state to particulate form through chemical transformation. The sulfite reducing agent converts soluble selenium oxyanions into particulate selenium that can rapidly settle, accelerating the separation process and improving productivity without sacrificing removal efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves selenium removal rates up to 96% or lower concentrations down to 1 ppb, meeting regulatory standards with potential synergistic effects and efficient selenium removal across various industrial fluids.
Implementation Method 1
adding one or more coagulants, e.g., at least one iron containing coagulant, and one or more reducing agents e.g., at least one sodium sulfite-based reducing agent, in an amount effective to reduce the amount of and/or remove at least a portion of the selenium from said fluid
Implementation Method 2
adding one or more coagulants, e.g., at least one iron containing coagulant, and one or more reducing agents e.g., at least one sodium sulfite-based reducing agent, in an amount effective to reduce the amount of and/or remove at least a portion of the selenium from said fluid
Implementation Method 3
optionally adding one or more flocculants to said fluid
Implementation Method 4
allowing the sludge to settle; and separating the selenium from the fluid
Data Source
AI summary
The present embodiments generally relate to methods and compositions for the removal of selenium from a fluid in need of treatment, such as, for example, industrial wastewaters. The methods and compositions for the removal of selenium generally comprise the use of one or more coagulants, such as at least one iron-containing coagulant, and one or more reducing agents, such as at least one sodium sulfite-based reducing agent.